CM-Path share top priorities for 2019-21

With its new chair, Professor David Harrison, at the helm, CM-Path share top priorities NCRI’s Cellular Molecular Pathology Initiative (CM-Path) was established in 2016 to bring together experts from pathology and other fields to build a stronger skills and resource base for the UK to undertake pathology research. A collaboration of NCRI Partners has committed [...]

By | November 19th, 2019|Whats new|0 Comments

New CM-Path Chairperson announced

The NCRI are pleased to announce that Professor David Harrison has been appointed to the CM-Path Chair position as of 1st August 2019 after a competitive interview process. David will be working with the CM-Path Executive Group and CM-Path members to deliver the vision and ambitious objectives of the programme over the next two years. [...]

By | August 14th, 2019|Whats new|0 Comments

Registration open for CM-Path Biobanking Workshop – ‘Do we really need another biobank?’

Tuesday 14th May All day The Francis Crick Institute, 1 Midland Rd, London NW1 1ST More about this event Biobanks can provide essential support for research but can be difficult to set up and expensive to run. In this workshop you will hear from experts in the field about the barriers to success and how [...]

By | January 2nd, 2019|Whats new|0 Comments

Registration open for A Practical Guide to Pathology Research Workshop

Tuesday 2nd April 2019 All day Royal Society of Medicine, 1 Wimpole Street, London, W1G 0LZ More about this event The CM-Path biomarker workshop series aims at discussing the current and future challenges of innovative biomarker developments, and agreeing on the barriers for delivery of clinical diagnostics assays. The third workshop is organized by the CM-Path [...]

By | December 4th, 2018|Whats new|0 Comments

Read the CM-Path consensus statement on ‘What is the role of pathologists in the implementation of liquid biopsy technologies?’

CM-Path Discovery workstream held 'The Liquid Biopsy' Symposium on March 8th 2018. Following the day members of CM-Path worked in collaboration with CRUK and PHG Foundation to develop a consensus statement. » Download our Consensus Statement on What is the role of pathologists in the implementation of liquid biopsy technologies? (PDF)   The Consensus Statement was [...]

By | July 5th, 2018|Uncategorized, Whats new|0 Comments

The CM-Path Biobanking Sample Quality Improvement Tool is now live!

We are excited to announce that the CM-Path Biobanking Sample Quality Improvement Tool is now available for download from our website! The tool is a free, confidential self-assessment of how current practices within your biobank may impact the quality of the tissue samples stored. It is easy to use, with drop down answer lists, links [...]

By | May 17th, 2018|Uncategorized, Whats new|0 Comments

CT-PAG Call for Proposals is now open!

The first call for proposals for the Clinical Trials Pathology Advisory Group (CT-PAG) is now open. Download the CT-PAG Application Form and email this to the CM-Path Programme manager, Helen Pitman Deadline for applications is Saturday 30th June 2018 For more information on CT-PAG please click here

By | April 30th, 2018|Whats new|0 Comments

CM-Path Publishes Report – Awareness amongst Pathologists of NCRI CSGs

CM-Path Clinical Trials Worktream undertook a survey of over 140 pathologists aiming to gauge awareness of the NCRI CSGs. The results were published in the January 2018 bulletin of the Royal College of Pathologists. Click on the link below to read the full report: » Awareness among pathologists of National Cancer Research Institute Clinical [...]

By | March 19th, 2018|Whats new|0 Comments

Biobanking Best Practices Workshop: Registration now open!

The aim of this event is to demonstrate the the importance of sample quality in biobanking. The intention is to engage the biobanking community and encourage uptake of the CM-Path Biobanking Sample Quality Improvement Tool in order to future proof historic sample collection. There is a registration fee of £100 per delegate. This event is [...]

By | March 8th, 2018|Whats new|0 Comments

CM-Path posts a BMJ Opinion Blog

CM-Path members Professor Manuel Salto-Tellez (Workstream 1 Co-Lead) and Dr David Moore (Workstream 1 member) have published a blog in the BMJ. The blog can be accessed here. Pathology risks being left behind as conceptual and technological advances accelerate Back in 2007 a diagnostic biopsy from a patient with lung cancer would frequently yield a [...]

By | January 2nd, 2018|Whats new|0 Comments